Getting Ozempic covered by insurance is straightforward if you have a type 2 diabetes diagnosis, but it requires navigating prior authorizations, step therapy, and sometimes appeals. Most commercial insurance plans cover Ozempic for its FDA-approved use in type 2 diabetes, though your out-of-pocket cost depends on your specific plan, deductible, and whether you’ve met certain clinical requirements your insurer sets.
What Insurance Actually Covers
Ozempic is FDA-approved for three uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of heart attack, stroke, and cardiovascular death in people with established heart disease, and protecting kidney function in people with chronic kidney disease. Insurance coverage aligns closely with these approved uses.
If you’re hoping to get Ozempic covered for weight loss alone, the odds are poor. Ozempic is not approved for weight management, and most private insurers and federal programs won’t cover it for that purpose. Wegovy contains the same active ingredient but is specifically approved for chronic weight management. Even then, most private insurance companies and federal health programs don’t cover weight loss drugs, and Medicare has been legally prohibited from covering weight loss treatments since 2003. Some insurers will cover Wegovy if you have an obesity-related condition like high blood pressure or high cholesterol, but a high BMI alone often isn’t enough.
The Prior Authorization Process
Nearly every insurer requires prior authorization before they’ll pay for Ozempic. This means your doctor submits paperwork proving the prescription is medically necessary. The typical documentation includes your type 2 diabetes diagnosis, your A1C level, a list of other diabetes medications you’ve tried, and any relevant complications like cardiovascular disease or kidney problems.
Your doctor’s office handles most of this, but you can speed things along by making sure your medical records are up to date and that recent lab work is on file. If your doctor switches practices or you’re seeing a new provider, older records showing your treatment history are especially important.
Step Therapy: Medications You May Need to Try First
Many insurance plans require step therapy before they’ll approve Ozempic. This means you need to have tried one or more cheaper diabetes medications first, and your doctor must document that those treatments didn’t work well enough or caused side effects you couldn’t tolerate.
Metformin is the most common first step. It’s the standard starting medication for type 2 diabetes, and insurers expect to see that you’re currently taking it or that there’s a documented medical reason you can’t. Beyond metformin, your plan may require that you tried another diabetes drug, such as a sulfonylurea or an SGLT2 inhibitor, before moving to a GLP-1 medication like Ozempic. Your prescriber will need prescription claims or chart notes showing these earlier treatments were attempted.
If you genuinely can’t tolerate metformin (gastrointestinal side effects are common), make sure that’s clearly noted in your medical record. A vague mention isn’t enough. Your doctor should document the specific side effects and why continuing wasn’t feasible.
What to Do If Your Claim Is Denied
Denials are common, but they’re not the end of the road. The first thing to do is find out exactly why you were denied. Call your insurer and ask for a written explanation. The reason matters because it determines your next move.
If the denial says “not medically necessary,” check that the correct billing and diagnosis codes were used. Coding errors are a surprisingly frequent cause of denials. Then ask your doctor to write a letter of medical necessity explaining your condition, your treatment history, and why Ozempic is the appropriate next step. Resubmit the authorization with this letter attached.
If the denial categorizes Ozempic as “excluded” under your plan, make sure all of your relevant health conditions have been reported. Comorbidities like heart disease, sleep apnea, kidney disease, or uncontrolled blood sugar strengthen your case. A letter from your doctor detailing these conditions, along with corrected codes if needed, should accompany the resubmission.
For employer-sponsored self-insured plans, you’ll need a formal written denial, usually in the form of an Explanation of Benefits. You then have 60 days from receiving that letter to file a written appeal. The plan must respond within 60 days. If you have a fully insured policy through a state-regulated plan, most states offer an external review process. You can request this independent review within 365 days of receiving the final decision letter from your insurer. An external reviewer who isn’t affiliated with your insurance company will evaluate whether the denial was appropriate.
Lowering Your Copay With the Savings Card
Even with insurance coverage, your copay for Ozempic can be significant, especially if you haven’t met your deductible. Novo Nordisk, the company that makes Ozempic, offers a savings card that knocks up to $100 off your monthly cost. The card is good for up to 48 months, which is a generous window compared to most manufacturer coupons.
There are restrictions. You must have commercial insurance that already covers Ozempic. If you’re on Medicare, Medicaid, Tricare, or any other government insurance, you’re not eligible. You can sign up directly through the Ozempic website, and your pharmacy applies the discount at the point of sale.
Options If You’re Uninsured
If you don’t have insurance at all, Novo Nordisk runs a Patient Assistance Program that provides Ozempic at no cost to qualifying patients. To be eligible, your total household income must be at or below 200% of the federal poverty level. For a single person in 2025, that’s roughly $31,000 per year. You apply through the NovoCare website, and your doctor will need to verify your prescription.
Uninsured patients who don’t qualify for the assistance program can still use the savings card, but the discount is processed outside of any insurance. That means it won’t count toward a deductible or out-of-pocket maximum on a future plan.
Practical Steps to Improve Your Chances
Before your doctor submits the prior authorization, a few things make approval more likely. Keep your lab work current, particularly your A1C. If your A1C is above the threshold your insurer uses (often 7% or higher, though this varies by plan), that strengthens the case. Make sure your medical record reflects every diabetes medication you’ve tried, how long you were on it, and why it was stopped or isn’t sufficient.
Ask your doctor’s office if they have experience with prior authorizations for GLP-1 medications. Offices that do this regularly know which forms to use and what language insurers respond to. If your doctor is unfamiliar with the process, an endocrinologist’s office may be better equipped to handle it.
Finally, call your insurance company directly before starting the process. Ask whether Ozempic is on your plan’s formulary, what tier it’s on, whether step therapy applies, and what documentation they need. Having this information upfront saves weeks of back-and-forth and lets your doctor tailor the authorization to your plan’s specific requirements.